These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 25849595)

  • 1. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
    Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
    PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.
    Liu L; Xu X; Jing L; Zhou G; Cao Z; Han Y; Zhou R
    PLoS One; 2015; 10(2):e0118026. PubMed ID: 25689860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.
    Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R
    Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
    Meng F; Tan S; Liu T; Song H; Lou G
    Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study.
    Meng F; Luo C; Hu Y; Yin M; Lin M; Lou G; Zhou R
    Int J Gynecol Pathol; 2010 Nov; 29(6):587-93. PubMed ID: 20881850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.
    Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC
    Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma.
    Meng FL; Yin MZ; Song HT; Yang H; Lou G; Zhou RL
    Int J Gynecol Cancer; 2010 Jul; 20(5):745-50. PubMed ID: 20966643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
    Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
    J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.
    Qiao M; Hu G
    Tumour Biol; 2015 Sep; 36(10):7493-9. PubMed ID: 25910706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
    Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
    J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer.
    Zhang H; Wei Q; Liu R; Qi S; Liang P; Qi C; Wang A; Sheng B; Li L; Xu Y
    PLoS One; 2014; 9(3):e91069. PubMed ID: 24651764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
    Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
    Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of GOLPH2 is associated with the progression of and poor prognosis in gastric cancer.
    Liu G; Zhang Y; He F; Li J; Wei X; Li Y; Liao X; Sun J; Yi W; Niu D
    Oncol Rep; 2014 Nov; 32(5):2077-85. PubMed ID: 25119897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
    Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAPTM4B-35 protein as a potential therapeutic target in gastric cancer.
    Zhang H; Tian B; Yu H; Yao H; Gao Z
    Tumour Biol; 2014 Dec; 35(12):12737-42. PubMed ID: 25416438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
    Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
    Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
    Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
    PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.